New partners reinvigorate a once-touted cancer treatment.
Where this comes from
- Record sourced from PubMed, PMID 37200438.
- Also identified by DOI 10.1126/science.adi7657.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Decades after faltering, angiogenesis inhibitors show new promise when paired with checkpoint drugs.
Medical subject headings
- Angiogenesis Inhibitors
- Immune Checkpoint Inhibitors
- Neoplasms